- Home
- PRTS vs ITRM Comparison
PRTS vs ITRM Comparison
Compare PRTS & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- ITRM
- Stock Information
- Founded
- PRTS 1995
- ITRM 2015
- Country
- PRTS United States
- ITRM Ireland
- Employees
- PRTS N/A
- ITRM N/A
- Industry
- PRTS Auto & Home Supply Stores
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- ITRM Health Care
- Exchange
- PRTS Nasdaq
- ITRM Nasdaq
- Market Cap
- PRTS 40.0M
- ITRM 40.0M
- IPO Year
- PRTS 2007
- ITRM 2018
- Fundamental
- Price
- PRTS $0.94
- ITRM $0.70
- Analyst Decision
- PRTS Hold
- ITRM Strong Buy
- Analyst Count
- PRTS 1
- ITRM 2
- Target Price
- PRTS $0.70
- ITRM $7.00
- AVG Volume (30 Days)
- PRTS 1.4M
- ITRM 768.7K
- Earning Date
- PRTS 10-28-2025
- ITRM 08-05-2025
- Dividend Yield
- PRTS N/A
- ITRM N/A
- EPS Growth
- PRTS N/A
- ITRM N/A
- EPS
- PRTS N/A
- ITRM N/A
- Revenue
- PRTS $577,614,000.00
- ITRM N/A
- Revenue This Year
- PRTS N/A
- ITRM N/A
- Revenue Next Year
- PRTS $2.62
- ITRM $249.35
- P/E Ratio
- PRTS N/A
- ITRM N/A
- Revenue Growth
- PRTS N/A
- ITRM N/A
- 52 Week Low
- PRTS $0.68
- ITRM $0.61
- 52 Week High
- PRTS $1.42
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- PRTS 55.54
- ITRM 45.26
- Support Level
- PRTS $0.70
- ITRM $0.61
- Resistance Level
- PRTS $1.36
- ITRM $0.70
- Average True Range (ATR)
- PRTS 0.11
- ITRM 0.06
- MACD
- PRTS 0.03
- ITRM 0.00
- Stochastic Oscillator
- PRTS 37.00
- ITRM 37.34
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.